Latest / Bloomberg Intelligence
Lilly’s Zepbound Cuts Risk of Diabetes
Watch Alix and Paul LIVE every day on YouTube: http://bit.ly/3vTiACF.
Sam Fazeli, Bloomberg Intelligence, Director of Research for Global Industries and Senior Pharmaceuticals, discusses how Eli Lilly’s drug Zepbound, cuts the risk of diabetes. Craig Trudell, Bloomberg Global Autos Editor, discusses the European Union saying it plans to introduce an additional 9% tariff on Teslas imported from China. Dryden Pence, CIO at Pence Wealth Management, joins to discuss his outlook for the markets. Henri Pierre-Jacques, Co-founder & Managing Partner, at Harlem Capital Partners, discusses current…
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.